Over the last 10 years, insiders at Zafgen have traded over 14,218,922$ worth of Zafgen stock and bought 689,531 units worth 3,998,442$ . The most active insiders traders include James E Deerfield Mgmt L.P....、Bruce Booth、Kevin P Starr. On average, Zafgen executives and independent directors trade stock every 53 days with the average trade being worth of 87,516$. The most recent stock trade was executed by Thomas E. Hughes on 28 June 2018, trading 32,000 units of ZFGN stock currently worth 320,000$.
Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.
Zafgen executives and other stock owners filed with the SEC include: